Abstract:Hepatocellular carcinoma (HCC), the fifth most prevalent cancer worldwide, is influenced by a myriad of clinic-pathological factors, including viral infections and genetic abnormalities. This study delineates the synthesis, characterization, and the biological efficacy of iron oxide nanoparticles (Fe 3 O 4 ) and chitosan-coated iron oxide nanoparticles (Fe 3 O 4 -CS) against HCC. Analytical methods confirmed the successful synthesis of both nanoparticles, with Fe 3 O 4 -CS demonstrating a smaller, uniform spherical morphology and distinct surface and magnetic properties attributable to its chitosan coating. The prepared materials were analyzed using various techniques, and their potential cytotoxic effects on HepG2 cancer cells line for HCC were investigated. In biological evaluations against HepG2 cells, a notable distinction in cytotoxicity was observed. Fe 3 O 4 showed modest anticancer activity with an IC50 of 383.71 ± 23.9 μg/mL, whereas Fe 3 O 4 exhibited a significantly enhanced cytotoxic effect, with a much lower IC50 of 39.15 ± 39.2 μg/mL. The Comet assay further evidenced Fe 3 O 4 -CS potent DNA damaging effect, showcasing its superior ability to induce apoptosis through extensive DNA fragmentation. Biochemical analyses integrated into our results reveal that Fe 3 O 4 -CS not only induces significant DNA damage but also markedly alters oxidative stress markers. Compared to control and Fe 3 O 4 -treated cells, Fe 3 O 4 -CS exposure significantly elevated levels of oxidative stress markers: superoxide dismutase (SOD) increased to 192.07 U/ml, catalase (CAT) decreased to 0.03 U/L, glutathione peroxidase (GPx) rose dramatically to 18.76 U/gT, and malondialdehyde (MDA) levels heightened to 30.33 nmol/gT. These results underscore the potential of Fe 3 O 4 -CS nanoparticles not only in inducing significant DNA damage conducive to cancer cell apoptosis but also in altering enzymatic activities and oxidative stress markers, suggesting a dual mechanism of action that may underpin their therapeutic advantage in cancer treatment. Our findings advocate for the further exploration of Fe 3 O 4 -CS nanoparticles in the development of anticancer drugs, emphasizing their capability to trigger oxidative stress and enhance antioxidant defense mechanisms.

Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress

Anti-melanoma Effect and Action Mechanism of a Novel Chitosan-Based Composite Hydrogel Containing Hydroxyapatite Nanoparticles

Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44

Potential mitochondrial ROS-mediated damage induced by chitosan nanoparticles bee venom-loaded on cancer cell lines

Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy

In Vitro and in Vivo Suppression of Hepatocellular Carcinoma Growth by Chitosan Nanoparticles

Enhanced Biocompatibility by Evaluating the Cytotoxic and Genotoxic Effects of Magnetic Iron Oxide Nanoparticles and Chitosan on Hepatocellular Carcinoma Cells (HCC)

Enhanced cytotoxic and apoptotic potential in hepatic carcinoma cells of chitosan nanoparticles loaded with ginsenoside compound K

Selective Killing of Cancer Cells by Silica Nanoparticles Due to Increased Nanoparticle Internalization and Cellular Sensitivity to Oxidative Stress

Cu 2+ –Citrate–Chitosan Complex Nanoparticles for the Chemodynamic Therapy of Lung Cancer

Genotoxicity Evaluation of Stearic Acid Grafted Chitosan Oligosaccharide Nanomicelles

Transcriptome Analysis Identifies Novel Mechanisms Associated with the Antitumor Effect of Chitosan-Stabilized Selenium Nanoparticles

Mitochondrion-targeted selenium nanoparticles stabilized by Sargassum fusiforme polysaccharides increase reactive oxygen species-mediated antitumour activity

Chitosan-encapsulated naringenin promotes ROS mediated through the activation of executioner caspase-3

Chitosan biguanide induced mitochondrial inhibition to amplify the efficacy of oxygen-sensitive tumor therapies

A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer<i> via</i> synergistic ROS augment and autophagy blockage

A Synergic Fabrication of Chitosan-Coated Salinomycin-Loaded Hydroxyapatite Potential Nanocarriers for the Treatment of Liver Cancer

Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application

Inhibition of thioredoxin reductase and upregulation of apoptosis genes for effective anti-tumor sono-chemotherapy by meso-organosilica nanomedicines

Biodegradable Hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB/ROS signaling

Selective Redox-Responsive Drug Release in Tumor Cells Mediated by Chitosan Based Glycolipid-Like Nanocarrier